pre-IPO PHARMA

COMPANY OVERVIEW

United Neuroscience (UNS) is a clinical-stage biotech company dedicated to the development of best-in-class immunotherapeutics for the brain.


LOCATION


THERAPEUTIC AREAS


WEBSITE

https://unitedneuroscience.com/


CAREER WEBSITE

None


SOCIAL MEDIA


INVESTORS



PRESS RELEASES


Apr 1, 2021

COVAXX and United Neuroscience Are Now Vaxxinity


Mar 28, 2019

United Neuroscience to Present Data on Alzheimer's Vaccine at the 2019 AD/PD Conference


Jan 16, 2019

United Neuroscience Announces Positive Top-Line Results from Phase 2a Clinical Study of UB-311 Vaccine in Patients with Alzheimer's Disease


Dec 21, 2018

United Neuroscience Names Peter Powchik, M.D, Executive Vice President of Research and Development


Nov 13, 2018

United Neuroscience Strengthens Vaccine Pipeline with Novel Immunotherapy for Parkinson's Disease


For More Press Releases


Google Analytics Alternative